Type 2 Diabetes Clinical Trials
Type 2 Diabetes
Not DisclosedActive
Key Facts
About American Health Research
American Health Research is a private, service-oriented clinical research organization (CRO) site that partners with pharmaceutical companies to conduct Phase I-IV clinical trials. It has built a dedicated facility with on-site diagnostic and laboratory capabilities, focusing on therapeutic areas like COPD, asthma, and Type 2 Diabetes. The company is led by its founder, Dr. Selwyn Spangenthal, and emphasizes regulatory compliance, certified staff, and patient-centric operations to generate reliable data for its sponsors. Its business model is based on service fees from clinical trial management, placing it in the 'Revenue Generating' stage.
View full company profileTherapeutic Areas
Other Type 2 Diabetes Drugs
| Drug | Company | Phase |
|---|---|---|
| Diabetes Management Gel | Gelteq Limited | Formulation Development |
| Tolimidone | Biodexa Pharmaceuticals | Phase 2 |
| Generic Semaglutide Injection (Obeda) | Dr. Reddy's Laboratories | Approved |
| BioChaperone® Lispro | Adocia | Phase 3 |
| BioChaperone® Combo (Insulin Glargine / Lixisenatide) | Adocia | Phase 2 |
| Metformin API | USV Biologics Division | Commercial |
| Empagliflozin | Azico Biophore | Commercial |
| Sitagliptin Intermediate | AR Life Science | Commercial |
| AJN003 (LuCI™) | AltrixBio | Pre-clinical |
| Sitagliptin Phosphate Polymorph | Morepen Laboratories | Pre‑clinical |
| Hepatic Denervation for Type 2 Diabetes | Metavention | Feasibility |
| MVD-1 (SANA) | Eolo Pharma | Discovery |